Posted by on July 16, 2020 11:01 am
Categories: Uncategorized

CRISPR Gene/Genome Editing Life Sciences in North America & Europe, 2020 – Developed from Responses to a 29-Question Survey Completed by 368 Scientists – PRNewswire

DUBLIN, July 16, 2020 /PRNewswire/ — The “2020 CRISPR Gene/Genome Editing Life Science Dashboard Series 1 – NA & EU” report has been added to’s offering.

As life science suppliers continue to improve products and services the CRISPR gene/genome editing market, represents a significant opportunity within the life sciences industry.

The 2020 CRISPR Gene/Genome Editing Life Science Dashboard is the first in a series that characterizes the dynamic market for products for CRISPR experiments.

This 2020 Dashboard provides a snapshot of the current market landscape, with the future goal of repeating and publishing the study to give Dashboard readers the ongoing story of how the market is adapting to new products, new competitors and new sales and marketing strategies.

The 2020 CRISPR Gene/Genome Editing Dashboard was developed from responses to a 29-question survey completed by 368 scientists located in North America and Europe. This Dashboard reveals key market indicators for the CRISPR market as a whole as well as for the following techniques representing market sub-segments:

  • Cas9 protein (e.g. Cas9/Cas12a nucleases, Cas9-nickase)
  • Cas9 mRNA
  • Guide RNA (synthetic)
  • Guide RNA (in vitro transcribed)
  • CRISPR libraries/library pools
  • CRISPR/Cas9 plasmid/mammalian expression systems
  • CRISPR/Cas9 viral/viral delivery systems (e.g. lentivirus, AAV)
  • HDR knockin reagents (e.g. ssDNA, oligos, plasmids)
  • Immunologic CRISPR detection tools (e.g. antibody, ELISA, FACS)
  • Kits/products for detection of editing (e.g. indel/editing/cleavage detection)
  • This report is focused on the use of CRISPR gene/genome editing products in the life science research market

The following suppliers were surveyed for this report:

  • Abcam
  • Addgene
  • Agilent/Stratagene
  • Applied Biological Materials (ABM)
  • BioLegend
  • BioTechne/Novus/R&D Systems
  • Cell Signaling Technologies
  • Diagenode
  • Epigentek
  • GeneCopoeia
  • GenScript
  • Horizon Discovery/Dharmacon
  • Integrated DNA Technologies (IDT)
  • Millipore/Sigma Aldrich/Merck
  • New England Biolabs
  • Origene
  • Promega
  • Santa Cruz Biotechnology
  • Synthego
  • Clontech/Takara
  • Thermo Fisher Scientific/Life Technologies/Invitrogen/Ambion/Pierce
  • Twist Bioscience

Key Topics Covered

  1. Executive Summary
  2. Dashboard at a Glance
  3. Market Opportunity Matrix
  4. Respondents Qualification
  5. Demographics
  6. Frequency of Performance: Life Science Techniques
  7. Frequency of Use: CRISPR Gene / Genome Editing
  8. Co-Performance: CRISPR Gene / Genome Editing Experiments & Life Science Techniques
  9. Throughput, Growth Rates, Price & Monthly Spend
  10. Market Size
  11. Percent of Spend with Suppliers by Segment (Share of Budget)
  12. Customer Satisfaction & Interest in Switching
  13. Purchase Decision Factors: Product Features
  14. Primary Downstream Application
  15. Desired Product Changes
  16. Appendix I: Supporting Data
  17. Appendix II: Percepta Capabilities and Life Science Dashboards Available

For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

Published at Thu, 16 Jul 2020 14:45:00 +0000